Drug Discovery
The drug Kin.001 is at the beginning of the clinical trial phase and will be on the market at the end of 2022, said CEO Alexander Bausch in a video report ...
June 02, 2021 | News
Novartis has also decided on early termination of the RAPTOR and RAVEN studies, which assessed the efficacy and safety of brolucizumab in retinal vein occl...
May 30, 2021 | News
Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that bas...
May 31, 2021 | News
To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck, a leading science and technology company, has launched ...
May 26, 2021 | News
The goal is to assess the utility of combining Nanoform's nanoparticle platform technologies with Celanese's VitalDose® EVA copolymer delivery tec...
May 26, 2021 | News
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high...
May 24, 2021 | News
Lipid-polymer nanocomplexeHello News Desk,s (LPNCs) developed by Mirus enable superior transfection performance in a range of delivery applications Inve...
May 20, 2021 | News
A*STAR has worked together with the local research ecosystem , including Temasek Foundation, Temasek Life Sciences Laboratory, Institutes of High...
May 18, 2021 | News
Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups High immune response after a ...
May 17, 2021 | News
Positive regulatory advice received for development plan to provide POC in late-stage COVID-19 patients Additional opportunities in indications related ...
May 17, 2021 | News
Bharat Biotech has established an excellent track record of innovation with more than 145 global patents, a wide product portfolio of more than 16 vaccines...
May 16, 2021 | News
As the world joins together to fight the ongoing battle against the COVID-19 pandemic, Terumo Corporation (TSE: 4543) has announced that the Terumo Group c...
May 14, 2021 | News
Australian pharmaceutical group Phebra ('Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP43...
May 14, 2021 | News
Merck Highlights Scientific Data at 2021 ASCO Annual Meeting Across More Than 20 Cancer Types From Broad Oncology Research Program Merck (NYSE: MR...
May 13, 2021 | News
Most Read
Bio Jobs
News